Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Melinta Therapeutics

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2DELAFLOXACIN MEGLUMINE

    02 2ORITAVANCIN DIPHOSPHATE

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    Brand Name : BAXDELA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Brand Name : BAXDELA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DELAFLOXACIN MEGLUMINE

    Melinta Therapeutics

    Dosage Form : TABLET; ORAL

    Proprietary Name : BAXDELA

    Dosage Strength : EQ 450MG BASE

    Approval Date : 2017-06-19

    Application Number : 208610

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : BAXDELA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Brand Name : BAXDELA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DELAFLOXACIN MEGLUMINE

    Melinta Therapeutics

    Dosage Form : POWDER; INTRAVENOUS

    Proprietary Name : BAXDELA

    Dosage Strength : EQ 300MG BASE/VIAL

    Approval Date : 2017-06-19

    Application Number : 208611

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : ORBACTIV

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Brand Name : ORBACTIV

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    ORITAVANCIN DIPHOSPHATE

    Melinta Therapeutics

    Dosage Form : POWDER; INTRAVENOUS

    Proprietary Name : ORBACTIV

    Dosage Strength : EQ 400MG BASE/VIAL

    Approval Date : 2014-08-06

    Application Number : 206334

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : KIMYRSA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow

    Brand Name : KIMYRSA

    U.S.A
    2024 ACI Convention
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    ORITAVANCIN DIPHOSPHATE

    Melinta Therapeutics

    Dosage Form : POWDER; INTRAVENOUS

    Proprietary Name : KIMYRSA

    Dosage Strength : EQ 1.2GM BASE/VIAL

    Approval Date : 2021-03-12

    Application Number : 214155

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place